EQUITY RESEARCH MEMO

micromod Partikeltechnologie

Generated 6/21/2026

Executive Summary

Conviction (model self-assessment)65/100

Micromod Partikeltechnologie is a German nanotechnology company specializing in the development and production of monodisperse micro- and nanoparticles and their coatings. Founded in 1991 and headquartered in Rostock, the company serves as a reliable supplier of system components for in-vitro diagnostics, high-throughput screening, magnetic bioseparation, and cell labeling. With over three decades of experience, micromod has established itself as a key player in the nanoparticle space, enabling novel diagnosis and therapy methods. The company's core strengths lie in its precise particle engineering and coating technologies, which are critical for applications such as magnetic separation and drug delivery. While micromod operates in a competitive landscape dominated by larger life science players, its niche focus and long-standing reputation provide a moat. The company is privately held with no disclosed funding or valuation, suggesting a conservative growth strategy. Given the growing demand for advanced diagnostics and personalized medicine, micromod is well-positioned to benefit from trends in biotech R&D.

Upcoming Catalysts (preview)

  • Q4 2026Expansion into therapeutic nanoparticle delivery40% success
  • H1 2027Strategic partnership with a major diagnostics OEM50% success
  • Q2 2026Launch of next-gen magnetic beads for bioseparation60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)